The Vanguard Group, Inc. has recently announced that it has increased stake in Sana Biotechnology Inc (NASDAQ:SANA) by 1.06%. After grabbing 9.01 million shares, the institutional investor is now in possession of 94420.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.57% having worth around $36.57 million. Moreover, T. Rowe Price Associates, Inc. increased its share by 1.87 million to have a control over 6.96 million shares. And BlackRock Fund Advisors raised its holdings to 98711.0 shares by acquiring 6.83 million shares or 3.46% of the stake.
Sana Biotechnology Inc (SANA) concluded trading on 01/10/24 at a closing price of $7.18, with 63.2 million shares of worth about $453.77 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 15.25% during that period and on Wednesday the price saw a gain of about 39.28%. Currently the company’s common shares owned by public are about 191.02M shares, out of which, 99.05M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 20 times over the past 12 months. They bought 24,429 shares in 6 of the transactions. In 14 selling transactions, insiders dumped 12,526,517 shares.
Canada Pension Plan, Scottish Mortgage Investment Trus, and Fidelity Growth Company Fund are the top 3 mutual funds which are holding stakes in Sana Biotechnology Inc Canada Pension Plan is currently holding 10.18 million shares of worth totaling $41.31 million. The company recently came buying 0.0 shares which brought its stake up to 5.16% of the company’s outstanding shares. Fidelity Growth Company Fund, after buying 2.98 million shares, have now control over 1.51% of the stake in the company. It holds 82800.0 shares of worth $12.09 million.
Sana Biotechnology Inc (NASDAQ: SANA) started trading at $5.18, above $0.02 from concluding price of the previous day. Stock saw a price change of 52.77% in past 5 days and over the past one month there was a price change of 93.01%. Year-to-date (YTD), SANA shares are showing a performance of 75.98% which increased to 91.98% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.74 but also hit the highest price of $8.01 during that period. The average intraday trading volume for Sana Biotechnology Inc shares is 1.62 million. The stock is currently trading 67.69% above its 20-day simple moving average (SMA20), while that difference is up 81.04% for SMA50 and it goes to 47.06% higher than SMA200.
The Vanguard Group, Inc. acquired 9.01 million shares of Sana Biotechnology Inc having value of about $36.57 million. Data submitted at the U.S SEC by The Vanguard Group, Inc. revealed that the firm now holds 94420.0 shares in the company valued at close to $677935.6, or have control over 1.06% stake in the company. Sana Biotechnology Inc (NASDAQ: SANA) currently have 191.02M outstanding shares and institutions hold larger chunk of about 46.82% of that. Holding of mutual funds in the company is about 29.36% while other institutional holders and individual stake holders have control over 44.75% and 17.51% of the stake respectively.
The stock has a current market capitalization of $1.42B and its 3Y-monthly beta is at 1.18. It has posted earnings per share of -$1.44 in the same period. It has Quick Ratio of 4.19 while making debt-to-equity ratio of 0.26. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SANA, volatility over the week remained 26.61% while standing at 13.10% over the month.
Analysts are in expectations that Sana Biotechnology Inc (SANA) stock would likely to be making an EPS of -$0.38 in the current quarter, while forecast for next quarter EPS is -$0.32 and it is -$1.08 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.42 which is -$0.33 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.38 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 14.99% while it is estimated to increase by 27.80% in next year.
Analysts at 7 brokerage firms have issued recommendations for the Sana Biotechnology Inc (SANA)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.86. Out of those 7 Wall Street analysts, 4 recommended a “Buy” rating, while 3 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JMP Securities on September 25, 2023 offering a Mkt outperform rating for the stock and assigned a target price of $9 to it.
